Lakshminarayanan Nandagopal
Hematology Oncology Associates of Fredericksburg(US)
Publications by Year
Research Areas
Prostate Cancer Treatment and Research, Bladder and Urothelial Cancer Treatments, Renal cell carcinoma treatment, Cancer Genomics and Diagnostics, Renal and related cancers
Most-Cited Works
- → Kidney Cancer, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology(2022)636 cited
- → Bladder Cancer, Version 3.2020, NCCN Clinical Practice Guidelines in Oncology(2020)623 cited
- → NCCN Guidelines® Insights: Bladder Cancer, Version 2.2022(2022)293 cited
- → NCCN Guidelines Insights: Kidney Cancer, Version 2.2020(2019)292 cited
- → NCCN Guidelines Insights: Kidney Cancer, Version 1.2021(2020)250 cited
- → Obesity diminishes response to PD-1-based immunotherapies in renal cancer(2020)85 cited
- → Circulating tumor DNA alterations in patients with metastatic castration‐resistant prostate cancer(2019)51 cited
- → Bronchoscopy can be done safely in patients with thrombocytopenia(2015)31 cited
- → Circulating Biomarkers in Bladder Cancer(2016)29 cited
- → Investigational MET inhibitors to treat Renal cell carcinoma(2019)28 cited